Rockefeller Capital Management L.P. Trims Position in HCA Healthcare, Inc. (NYSE:HCA)

Rockefeller Capital Management L.P. cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,444 shares of the company's stock after selling 1,646 shares during the period. Rockefeller Capital Management L.P.'s holdings in HCA Healthcare were worth $6,439,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in HCA. Barclays PLC boosted its holdings in shares of HCA Healthcare by 22.3% in the third quarter. Barclays PLC now owns 571,975 shares of the company's stock worth $232,467,000 after buying an additional 104,409 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in HCA Healthcare in the 3rd quarter worth $688,000. Franklin Resources Inc. increased its position in HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company's stock worth $660,842,000 after buying an additional 174,946 shares in the last quarter. American Trust purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at about $372,000. Finally, Oddo BHF Asset Management Sas purchased a new position in HCA Healthcare during the third quarter valued at approximately $3,278,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analysts Set New Price Targets

HCA has been the topic of a number of analyst reports. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Robert W. Baird reissued a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Royal Bank of Canada reduced their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research report on Monday, January 27th. Barclays dropped their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. Finally, KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $381.67.

HCA Healthcare Stock Up 3.5 %

Shares of NYSE:HCA traded up $11.52 on Wednesday, reaching $336.14. The company had a trading volume of 374,896 shares, compared to its average volume of 1,382,649. The firm has a market capitalization of $82.76 billion, a PE ratio of 15.30, a PEG ratio of 1.10 and a beta of 1.48. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm's 50 day simple moving average is $328.71 and its 200-day simple moving average is $333.13. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the business earned $5.90 earnings per share. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio (DPR) is currently 13.11%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.